Influenza vaccination in children with cancer receiving chemotherapy

Susanna Esposito, Valerio Cecinati, Fabio Giovanni Russo, Nicola Principi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Influenza has a significant clinical impact on pediatric cancer patients because it causes frequent febrile episodes and respiratory tract infections, possibly severe complications, delays in chemotherapy administration and even death, all of which supports the importance of prevention and the widespread use of influenza vaccination. Results from clinical studies show that influenza vaccination can be considered safe in children undergoing chemotherapy and, although weaker than in healthy children, the immune response seems to be sufficient in patients with leukemia or solid tumors even if it is less in children receiving chemotherapy than in those who are not. However, there is an urgent need for universally accepted guidelines concerning the type of vaccine that leads to the best immunological results, the number of administrations, and their timing in relation to the severity of immunosuppression and chemotherapy schedules. Such recommendations, together with a clear demonstration of vaccine efficacy, are also needed to increase influenza vaccination coverage in this high-risk category of patients.

Original languageEnglish
Pages (from-to)430-432
Number of pages3
JournalHuman Vaccines
Volume5
Issue number6
Publication statusPublished - 2009

Fingerprint

Human Influenza
Vaccination
Drug Therapy
Neoplasms
Vaccines
Respiratory Tract Infections
Immunosuppression
Appointments and Schedules
Leukemia
Fever
Guidelines
Pediatrics

Keywords

  • Children
  • Influenza
  • Influenza vaccination
  • Pediatric oncology
  • Prevention

ASJC Scopus subject areas

  • Immunology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Esposito, S., Cecinati, V., Russo, F. G., & Principi, N. (2009). Influenza vaccination in children with cancer receiving chemotherapy. Human Vaccines, 5(6), 430-432.

Influenza vaccination in children with cancer receiving chemotherapy. / Esposito, Susanna; Cecinati, Valerio; Russo, Fabio Giovanni; Principi, Nicola.

In: Human Vaccines, Vol. 5, No. 6, 2009, p. 430-432.

Research output: Contribution to journalArticle

Esposito, S, Cecinati, V, Russo, FG & Principi, N 2009, 'Influenza vaccination in children with cancer receiving chemotherapy', Human Vaccines, vol. 5, no. 6, pp. 430-432.
Esposito S, Cecinati V, Russo FG, Principi N. Influenza vaccination in children with cancer receiving chemotherapy. Human Vaccines. 2009;5(6):430-432.
Esposito, Susanna ; Cecinati, Valerio ; Russo, Fabio Giovanni ; Principi, Nicola. / Influenza vaccination in children with cancer receiving chemotherapy. In: Human Vaccines. 2009 ; Vol. 5, No. 6. pp. 430-432.
@article{e2ae5fd9cef1493ab3b0219bb116c91a,
title = "Influenza vaccination in children with cancer receiving chemotherapy",
abstract = "Influenza has a significant clinical impact on pediatric cancer patients because it causes frequent febrile episodes and respiratory tract infections, possibly severe complications, delays in chemotherapy administration and even death, all of which supports the importance of prevention and the widespread use of influenza vaccination. Results from clinical studies show that influenza vaccination can be considered safe in children undergoing chemotherapy and, although weaker than in healthy children, the immune response seems to be sufficient in patients with leukemia or solid tumors even if it is less in children receiving chemotherapy than in those who are not. However, there is an urgent need for universally accepted guidelines concerning the type of vaccine that leads to the best immunological results, the number of administrations, and their timing in relation to the severity of immunosuppression and chemotherapy schedules. Such recommendations, together with a clear demonstration of vaccine efficacy, are also needed to increase influenza vaccination coverage in this high-risk category of patients.",
keywords = "Children, Influenza, Influenza vaccination, Pediatric oncology, Prevention",
author = "Susanna Esposito and Valerio Cecinati and Russo, {Fabio Giovanni} and Nicola Principi",
year = "2009",
language = "English",
volume = "5",
pages = "430--432",
journal = "Human Vaccines",
issn = "1554-8600",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - Influenza vaccination in children with cancer receiving chemotherapy

AU - Esposito, Susanna

AU - Cecinati, Valerio

AU - Russo, Fabio Giovanni

AU - Principi, Nicola

PY - 2009

Y1 - 2009

N2 - Influenza has a significant clinical impact on pediatric cancer patients because it causes frequent febrile episodes and respiratory tract infections, possibly severe complications, delays in chemotherapy administration and even death, all of which supports the importance of prevention and the widespread use of influenza vaccination. Results from clinical studies show that influenza vaccination can be considered safe in children undergoing chemotherapy and, although weaker than in healthy children, the immune response seems to be sufficient in patients with leukemia or solid tumors even if it is less in children receiving chemotherapy than in those who are not. However, there is an urgent need for universally accepted guidelines concerning the type of vaccine that leads to the best immunological results, the number of administrations, and their timing in relation to the severity of immunosuppression and chemotherapy schedules. Such recommendations, together with a clear demonstration of vaccine efficacy, are also needed to increase influenza vaccination coverage in this high-risk category of patients.

AB - Influenza has a significant clinical impact on pediatric cancer patients because it causes frequent febrile episodes and respiratory tract infections, possibly severe complications, delays in chemotherapy administration and even death, all of which supports the importance of prevention and the widespread use of influenza vaccination. Results from clinical studies show that influenza vaccination can be considered safe in children undergoing chemotherapy and, although weaker than in healthy children, the immune response seems to be sufficient in patients with leukemia or solid tumors even if it is less in children receiving chemotherapy than in those who are not. However, there is an urgent need for universally accepted guidelines concerning the type of vaccine that leads to the best immunological results, the number of administrations, and their timing in relation to the severity of immunosuppression and chemotherapy schedules. Such recommendations, together with a clear demonstration of vaccine efficacy, are also needed to increase influenza vaccination coverage in this high-risk category of patients.

KW - Children

KW - Influenza

KW - Influenza vaccination

KW - Pediatric oncology

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=70349547089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349547089&partnerID=8YFLogxK

M3 - Article

C2 - 19221519

AN - SCOPUS:70349547089

VL - 5

SP - 430

EP - 432

JO - Human Vaccines

JF - Human Vaccines

SN - 1554-8600

IS - 6

ER -